Substituted 3,1-benzazasilines
    1.
    发明授权
    Substituted 3,1-benzazasilines 失效
    取代的3,1-苯并嗪

    公开(公告)号:US4175091A

    公开(公告)日:1979-11-20

    申请号:US881687

    申请日:1978-02-27

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: C07F7/08 C07F7/10

    CPC分类号: C07F7/0816 Y10S514/923

    摘要: Compounds of the following structure ##STR1## where R.sub.1 represents H or alkyl having 1-5 carbon atoms,R.sub.2, R.sub.3, R.sub.4 and R.sub.5 each, independently represents H or alkyl having 1-2 carbon atomsR.sub.6 represents H, alkyl having 1-5 carbon atoms, halo, alkoxy having 1-5 carbon atoms or ##STR2## where R.sub.8 and R.sub.9 each, independently, represent alkyl having 1-2 carbon atoms, andR.sub.7 represents alkyl having 1-5 carbon atoms,e.g., 1-(p-chlorophenyl)-1,4-dihydro-.beta.,.beta.,1-trimethyl-3,1-benzazasiline-3(2H)-ethanol, are prepared from corresponding oxazolo benzazasilanes by reduction with borohydride, and are useful as sleep inducers.

    摘要翻译: 其中R1表示H或具有1-5个碳原子的烷基,R2,R3,R4和R5各自独立地表示H或具有1-2个碳原子的烷基的下列结构的化合物R6表示H,具有1-5个 碳原子,卤素,具有1-5个碳原子的烷氧基或,其中R8和R9各自独立地表示具有1-2个碳原子的烷基,R7表示具有1-5个碳原子的烷基,例如1-(p - 氯苯基)-1,4-二氢-β,β,1-三甲基-3,1-苯并氮杂苯并-3(2H) - 乙醇通过用硼氢化钠还原由相应的恶唑并苯并氮杂硅烷制备,并且可用作睡眠诱导剂。

    Substituted 3,1-benzazasilin-4-ones
    4.
    发明授权
    Substituted 3,1-benzazasilin-4-ones 失效
    取代的3,1-苯并氮杂环己烷-4-酮

    公开(公告)号:US4132725A

    公开(公告)日:1979-01-02

    申请号:US881686

    申请日:1978-02-27

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: C07F7/08 C07F7/10

    摘要: Benzazasilin-4-ones of the formula ##STR1## where R.sub.1 represents H or alkyl of 1-5 carbon atoms,R.sub.2 represents alkyl of 1-5 carbon atoms,R.sub.3 represents alkyl of 1-5 carbon atoms or ##STR2## where R.sub.5 represents H, alkyl of 1-5 carbon atoms, halo having an atomic weight of about 19-36, alkoxy having 1-5 carbon atoms, or ##STR3## where R.sub.6 and R.sub.7 each, independently, represent alkyl having 1-2 carbon atoms, andR.sub.4 represents alkyl having 1-3 carbon atoms, e.g., 1-(p-chlorophenyl)-2,3-dihydro-1,3-dimethyl-3,1-benzazasilin-4(1H)-one, are prepared from the appropriate lithiated N-alkyl benzamide and a halomethyl halosilane and are useful as antiobesity agents or sleep inducers.

    摘要翻译: 其中R 1表示H或1-5个碳原子的烷基,R 2表示1-5个碳原子的烷基,R 3表示1-5个碳原子的烷基或(I)的苯并氮杂环己烷-4-酮, 其中R5表示H,1-5个碳原子的烷基,原子量约为19-36的卤素,具有1-5个碳原子的烷氧基,或者其中R6和R7各自独立地表示具有1-2个碳原子的烷基 碳原子,R 4表示具有1-3个碳原子的烷基,例如1-(对氯苯基)-2,3-二氢-1,3-二甲基-3,1-苯并氮杂环己烷-4(1H) - 酮,是 由适当的锂化N-烷基苯甲酰胺和卤代甲基卤代硅烷制备,可用作抗肥胖剂或睡眠诱导剂。

    Sulfur and silicon-containing fatty acid amides
    5.
    发明授权
    Sulfur and silicon-containing fatty acid amides 失效
    含硫和含硅脂肪酸酰胺

    公开(公告)号:US4434161A

    公开(公告)日:1984-02-28

    申请号:US427606

    申请日:1982-09-29

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: C07F7/08 C07F7/10

    摘要: Sulfur and silicon-containing amides, e.g. N-5-sila-3-thia-5,5-dimethyl-pentadecanoyl-1-phenyl-2-(4-methylphenyl)-ethylamine, are useful as anti-atherosclerotic agents. The amides are obtainable by acylation of a primary amine (the substituents on the amine being of the aralkyl phenyl, tryptophanyl, benzocycloalkyl-type) with a corresponding sulfur and silicon-containing carboxylic acid (or active form thereof).

    摘要翻译: 硫和含硅酰胺,例如 N-5-硅烷-3-硫杂-5,5-二甲基 - 十五烷酰基-1-苯基-2-(4-甲基苯基) - 乙胺可用作抗动脉粥样硬化剂。 酰胺可以通过用相应的含硫和含硅羧酸(或其活性形式)酰化伯胺(芳烷基苯基,色氨酰基,苯并环烷基型的胺上的取代基)来获得。

    1-Oxa-2,6-disilacyclohexane-4-carboxamides
    6.
    发明授权
    1-Oxa-2,6-disilacyclohexane-4-carboxamides 失效
    1-氧杂-2,6-二硅杂环己烷-4-甲酰胺

    公开(公告)号:US4415560A

    公开(公告)日:1983-11-15

    申请号:US433464

    申请日:1982-10-12

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: C07F7/08 C07F7/10

    CPC分类号: C07F7/0841 Y10S514/824

    摘要: Silicon-containing amides, e.g., N-[1'-phenyl-2'-(4"-methylphenyl)ethyl]-2,2,6,6-tetramethyl-1-oxa-2,6-disilacyclohexane-4-carboxamide, are useful as anti-atherosclerotic agents. The amides are obtainable by acylation of a primary amine (the substituents on the amine being of the aralkyl phenyl, tryptophanyl, benzocycloalkyl-type) with a corresponding silicon-containing carboxylic acid (or active form thereof).

    摘要翻译: 含硅酰胺,例如N- [1'-苯基-2' - (4“ - 甲基苯基)乙基] -2,2,6,6-四甲基-1-氧杂-2,6-二异丙基环己烷-4-酮 甲酰胺可用作抗动脉粥样硬化剂。 酰胺可以通过用相应的含硅羧酸(或其活性形式)酰化伯胺(芳烷基苯基,色氨酸,苯并环烷基型的胺上的取代基)来获得。

    4,4'-(Alkanediyl)-bis(2,2,6,6-tetraalkyl
-1-oxa-4-aza-2,6-disilacyclohexanes)
    7.
    发明授权
    4,4'-(Alkanediyl)-bis(2,2,6,6-tetraalkyl -1-oxa-4-aza-2,6-disilacyclohexanes) 失效
    4,4' - (烷二基) - 双(2,2,6,6-四烷基-1-氧杂-4-氮杂-2,6-二硅杂环己烷)

    公开(公告)号:US4374130A

    公开(公告)日:1983-02-15

    申请号:US227179

    申请日:1981-01-22

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: A61K31/695

    CPC分类号: C07F7/0843

    摘要: This disclosure describes compounds of the formula ##STR1## wherein n is 3, 5 or 7, andeach R is lower alkyl having 1 to 4 carbon atoms, or pharmaceutically acceptable acid addition salts thereof, which are useful as anti-diabetic agents in particular glucagon inhibiting agents.

    摘要翻译: 本公开内容描述了下式的化合物,其中n为3,5或7,并且每个R为具有1至4个碳原子的低级烷基,或其药学上可接受的酸加成盐,其可用作特别是抗糖尿病药 胰高血糖素抑制剂。

    Substituted 1-oxa-4-aza-2,6-disilacyclohexanes and use thereof
    8.
    发明授权
    Substituted 1-oxa-4-aza-2,6-disilacyclohexanes and use thereof 失效
    取代的1-氧杂-4-氮杂-2,6-二硅杂环己烷及其用途

    公开(公告)号:US4224317A

    公开(公告)日:1980-09-23

    申请号:US69734

    申请日:1979-08-27

    申请人: Sandor Barcza

    发明人: Sandor Barcza

    IPC分类号: A61K31/695 C07F7/10

    CPC分类号: C07F7/0843 Y10S514/906

    摘要: This disclosure describes compounds of the formula ##STR1## wherein R.sub.1 represents ##STR2## and R.sub.2, R.sub.3, R.sub.4 and R.sub.5 each independently represent lower alkyl having 1 to 2 carbon atoms, andn is 1 or 2,which are useful as muscle-relaxant agents.

    摘要翻译: 本公开内容描述了下式的化合物,其中R 1表示R 1,R 2,R 3,R 4和R 5各自独立地表示具有1至2个碳原子的低级烷基,n为1或2,其可用作肌肉松弛剂 代理商

    Para-amino benzoic and phenylacetic acid derivatives
    10.
    发明授权
    Para-amino benzoic and phenylacetic acid derivatives 失效
    对氨基苯甲酸和苯乙酸衍生物

    公开(公告)号:US4416876A

    公开(公告)日:1983-11-22

    申请号:US379739

    申请日:1982-05-19

    IPC分类号: C07F7/08 C07F7/10

    CPC分类号: C07F7/0818 Y10S514/824

    摘要: Compounds of the formula ##STR1## in which R.sup.1 is a mono-silicon-containing hydrocarbyl radical having up to 35 carbon atoms;each of R.sup.2 and R.sup.3 is, independently, a hydrogen atom or lower alkyl having from 1 to 3 carbon atoms;n is 0 or 1; andM is a hydrogen atom, an equivalent of a cation which forms a non-toxic, pharmaceutically acceptable salt, or a non-toxic pharmaceutically acceptable monovalent radical which is hydrolyzable or saponifiable to an alkali metal cation, eg sodium 4-(4,4-dimethyl-4-sila-tetradecylamino)-benzoate, are useful as pharmaceutical agents.

    摘要翻译: 其中R 1是具有至多35个碳原子的单硅含烃基的式I的化合物; R 2和R 3各自独立地为氢原子或具有1至3个碳原子的低级烷基; n为0或1; 并且M是氢原子,其等同于形成无毒的药学上可接受的盐或无毒的药学上可接受的单价基团的阳离子,其可碱解或可皂化为碱金属阳离子,例如4-(4, 4-二甲基-4-硅烷 - 十四烷基氨基) - 苯甲酸酯可用作药剂。